Why India’s new rules put science and lives at risk

america news 24 evidenza

What happens when the safeguards designed to protect animals in scientific experiments are dismantled? The immediate victims may be animals, but the consequences reach far beyond the laboratory. Poorly regulated experiments produce unreliable data. Unreliable data leads to flawed science. And flawed science can ultimately put human lives at risk.

This is why the proposed 2026 draft rules on animal experimentation should concern every Indian, not just animal welfare activists or the scientific community.

India spent decades building a regulatory framework to ensure that animal research was conducted humanely and scientifically. The Prevention of Cruelty to Animals Act, 1960, provided for oversight through the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). When the committee began exercising its regulatory role more actively around 2000, what it uncovered was deeply disturbing: appalling neglect, animals kept in grossly inadequate conditions and experiments that raised serious questions about scientific competence.

There were reports of 27 monkeys confined in birdcages for years. Equally alarming were experiments of dubious scientific value, including the repeated drowning of rats to establish the rather extraordinary proposition that a rat that is not asleep must be awake.

These were not simply instances of cruelty. They exposed a systemic failure of research standards, documentation and accountability.

The regulatory reforms that followed helped introduce world class GLP (good laboratory practices), strengthen oversight and eliminate unnecessary animal use in certain areas, including cosmetics testing. India subsequently emerged as a major pharmaceutical and vaccine manufacturing power. These achievements were built on scientific capability, institutional discipline and credible standards. Why would we now put that progress at risk?

The rules now being proposed by Naresh Gangwar, Secretary Animal Husbandry and Dr Muthukumarasamy, Chairman CCSEA, threaten to reverse much of this progress.

Consider their implications. Animals bred specifically for research could be replaced by animals obtained from virtually any source – shelters, streets, markets or elsewhere. How can researchers establish the medical history, genetic consistency or health status of such animals? If the experimental subjects are compromised, so is the research. This is not deregulation in the interests of science; it is an invitation to unreliable science.

The proposed relaxation of requirements governing laboratory environments is equally disturbing. Experiments conducted outside properly controlled facilities, potentially even in mobile setups, raise fundamental questions about hygiene, safety and reproducibility. Science depends on controlled conditions. A laboratory is not an administrative formality; it is a prerequisite for credible results.

Then there is the dilution of independent oversight. Instead of the existing level of central scrutiny, greater authority would rest with institutional ethics committees. Internal oversight has a role, but it cannot become a substitute for independent regulation. When institutions have commercial, financial or reputational interests in research outcomes, who ensures that convenience does not take precedence over ethics and scientific integrity?

Other provisions are just as troubling: inspections requiring prior intimation, starvation classified as a mild procedure, tumour induction and surgical genetic alterations categorised as moderate, reduced requirements for anaesthesia, blanket approvals for teaching and training lasting up to five years, inadequate checks against repetitive experiments and the possibility of indefinite animal reuse without clear rehabilitation or euthanasia provisions.

Taken together, these are not minor administrative adjustments. They represent a fundamental weakening of the system designed to prevent abuse.

There is also a glaring contradiction in the direction of India’s scientific policy. Globally, research is moving towards reducing dependence on animal models and developing more human-relevant alternatives. Human-cell-based testing, organoids, organ-on-chip technologies and computational models are opening new possibilities. Animal models have well-recognised limitations: biological differences between species mean that results in animals do not necessarily predict human responses. Penicillin, for instance, famously failed in animal tests yet proved to be a wonder drug for humans. 

India should be investing in these emerging technologies, building expertise, creating skilled jobs and attracting world-class research. We should compete because our science is better, not because our safeguards are weaker.

The public consultation process has raised further concerns. Following widespread objections during the 30-day feedback period ending November 5, a subsequent notification sought comments specifically from medical colleges registered with the National Medical Commission, with submissions copied to the NMC. Such a narrowing of participation to institutions regulated by government, raises legitimate questions about transparency and whether the full range of scientific, ethical and public concerns is actually being heeded or  whether this vital process is now being manipulated towards the desired outcome. 

Let us be clear: this is not about stopping medical research. It is about insisting that research be rigorous, independently monitored and ethically defensible. The internationally recognised principles of Replacement, Reduction and Refinement must translate into enforceable requirements, not remain convenient words in a policy document.

The question before India is simple: do we want to become a global leader in modern science, or a destination where experimentation is attractive precisely because oversight is easier to evade?

The cost of poor science is never confined to the laboratory. It is borne by patients, consumers, future generations and every citizen who places trust in the medicines and treatments developed in this country.

Animals cannot object to the conditions in which they are experimented upon. That silence must never be mistaken for consent.

India must withdraw these draft rules in their present form. Scientific progress cannot be built on the dismantling of safeguards. When we compromise the ethics of research, we ultimately compromise its credibility – and potentially our own safety.

Animals can’t comment on draft rules or read the fine print. That job falls to the rest of us, and it needs journalism that stays with a story after the first headline. Support our work here.

On a lighter note, Newslaundry now has an office cat, and she has no name. For Rs 99, you get two weeks of Newslaundry and a chance to name her.

Source link

Scroll to Top